Communities led by health information organizations were more likely than those led by healthcare organizations to receive ongoing funding for implementing health information technology.
Various changes to the Part D benefit were made in 2009, including availability of the data for research and increased cost of the standard benefit.
The experience of Partners HealthCare offers some unique insights into the process of electronic medical record adoption across a large, diverse health system.
The increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.
In a multicenter cohort of patients with newly diagnosed pulmonary hypertension, increased risk for mortality among African Americans was no longer observed after adjusting for insurance status.
Precision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.
This decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.
The pandemic of type 2 diabetes mellitus requires implementation of multifactorial interventions by clinicians for individual patients and policy makers for the health of the general public.
This study determined that ICD-9 codes 433.X1, 434.XX, and V12.54 had positive predictive values >90%, and may be used to focus care on stroke patients.